Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.865 USD | +0.27% | +1.91% | -40.22% |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 34.98M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -17M | EV / Sales 2021 | - |
Net cash position 2021 | 9.36M | Net cash position 2022 | 13.25M | EV / Sales 2022 | - |
P/E ratio 2021 |
-3.69
x | P/E ratio 2022 |
-1.65
x | Employees | 15 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.16% |
Latest transcript on Akari Therapeutics, Plc
1 day | +0.27% | ||
1 week | +1.91% | ||
Current month | -20.64% | ||
1 month | -15.99% | ||
3 months | -37.83% | ||
6 months | -54.29% | ||
Current year | -40.22% |
Managers | Title | Age | Since |
---|---|---|---|
Rachelle Jacques
CEO | Chief Executive Officer | 53 | 22-03-27 |
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.865 | +0.27% | 13,382 |
24-03-27 | 1.86 | -1.33% | 34,771 |
24-03-26 | 1.885 | -0.78% | 13,901 |
24-03-25 | 1.9 | +4.97% | 2,448 |
24-03-22 | 1.81 | -1.09% | 59,394 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.22% | 12.31M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |